Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Intestinal Diseases

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Intestinal Diseases in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's3 (37.50)18.2507
2000's3 (37.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brito, GA; Cunha, FQ; Justino, PF; Lima-Junior, RC; Mota, JM; Ribeiro, RA; Soares, PM; Souza, MH1
Ishii, S; Pinho, V; Shimizu, T; Soares, AC; Souza, DG; Teixeira, MM1
Caty, MG; Fung, HL; Khanna, A; Rossman, J1
Caplan, MS; De Plaen, IG; Hsueh, W; Qu, XW; Rozenfeld, RA; Thaete, LG; Zhu, Y1
Hsueh, W; Zhang, C1
Hsueh, W; Sun, XM1
Braquet, P; Drouet, Y; Droy-Lefaix, MT; GĂ©raud, G1
Hanahan, DJ1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Intestinal Diseases

ArticleYear
Platelet activating factor: a biologically active phosphoglyceride.
    Annual review of biochemistry, 1986, Volume: 55

    Topics: Animals; Blood Platelets; Capillary Permeability; Chemical Phenomena; Chemistry; Exocrine Glands; Humans; Hypotension; Intestinal Diseases; Leukemia; Liver; Macrophages; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled

1986

Other Studies

7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Intestinal Diseases

ArticleYear
Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:3

    Topics: Animals; Antimetabolites, Antineoplastic; Cytokines; Duodenum; Fluorouracil; Ginkgolides; Intestinal Diseases; Intestinal Mucosa; Lactones; Leukocyte Count; Leukopenia; Mice; Mice, Inbred BALB C; Mice, Knockout; Mucositis; Peroxidase; Platelet Activating Factor; Receptors, Platelet-Derived Growth Factor

2011
Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.
    British journal of pharmacology, 2003, Volume: 139, Issue:4

    Topics: Animals; Dihydropyridines; Disease Models, Animal; Imidazoles; Intestinal Diseases; Intestines; Lung Diseases; Male; Mesenteric Artery, Superior; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reperfusion Injury

2003
Beneficial effects of intraluminal nitroglycerin in intestinal ischemia-reperfusion injury in rats.
    The Journal of surgical research, 2003, Volume: 114, Issue:1

    Topics: Administration, Topical; Animals; Bile; Hemodynamics; Intestinal Diseases; Intestinal Mucosa; Intestines; Male; Models, Animal; Neutrophil Activation; Neutrophil Infiltration; Nitric Oxide; Nitroglycerin; Permeability; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Vasodilator Agents

2003
Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase.
    Critical care medicine, 2005, Volume: 33, Issue:5

    Topics: Animals; Antioxidants; Biopterins; Enzyme Inhibitors; Indazoles; Intestinal Diseases; Male; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Platelet Activating Factor; Pterins; Rats; Rats, Sprague-Dawley; Splanchnic Circulation

2005
PAF-induced bowel necrosis. Effects of vasodilators.
    Digestive diseases and sciences, 1991, Volume: 36, Issue:5

    Topics: Alprostadil; Animals; Hydralazine; Hypotension; Indazoles; Intestinal Diseases; Leukopenia; Male; Mesenteric Arteries; Necrosis; Nitroglycerin; Phenoxybenzamine; Platelet Activating Factor; Prazosin; Rats; Rats, Inbred Strains; SRS-A; Vasodilator Agents

1991
Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.
    Journal of immunology (Baltimore, Md. : 1950), 1991, Jul-15, Volume: 147, Issue:2

    Topics: Animals; Blood Pressure; Complement Activation; Complement C5; Dose-Response Relationship, Drug; Hematocrit; Intestinal Diseases; Leukocyte Count; Lipopolysaccharides; Mice; Mice, Mutant Strains; Necrosis; Neutrophils; Platelet Activating Factor; Shock; Tumor Necrosis Factor-alpha; Vinblastine

1991
Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat.
    Advances in experimental medicine and biology, 1990, Volume: 264

    Topics: Allopurinol; Animals; Dimethyl Sulfoxide; Diterpenes; Female; Free Radicals; Ginkgolides; Intestinal Diseases; Intestinal Mucosa; Ischemia; Lactones; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reperfusion Injury; Superoxide Dismutase

1990